Biomaterials that come in contact with blood require excellent antithrombogenicity. The antithrombogenicity of newly developed biomaterials is evaluated by in vitro tests and animal experiments. However, no in vitro evaluation system has been established that can suf ciently evaluate the complicated mechanisms of thrombus formation within the body. Even in animal experiments, it is dif cult to observe the chronology of thrombus formation in real time. In this study, we aimed to develop a method for the evaluation of antithrombogenicity of biomaterials. To this end, we examined the optical detection of platelet aggregation occurring on the surface of biomaterials. An apparatus that optically detects platelet aggregation in a test tube or in an in vitro blood circulation circuit was constructed. We used the luciferin-luciferase (L-L) reaction that emits light with an intensity proportional to the concentration of adenosine triphosphate (ATP) s released from platelets after aggregation on the surface of biomaterials. Blood with L-L luminescent reagent added was allowed to aggregate, and chronological changes in intensity of the resulting emission were detected using a photomultiplier tube. This experimental apparatus was able to detect the emission intensity corresponding to the amount of platelet aggregation. The results of in vitro blood circulation tests using a polyvinyl chloride tube or a porcine carotid artery showed a signi cant and strong correlation between maximum emission intensity based on platelet aggregation and dry weight of thrombus formed within the circulation circuit (r = 0.727, p = 0.007). Thus, this experimental system was proven to be useful as an alternative to animal experiments for the evaluation of antithrombogenicity of biomaterials.
Introduction
Arti cial organs such as arti cial valves and arti cial blood vessels that come in contact with blood, or biomaterials such as extracorporeal blood circulation devices used in arti cial heart-lung machines and hemodialysis therapy are associated with the risk of thrombus formation. The thrombus formed may be a risk factor for severe complications such as cerebral infarction. Therefore, biomaterials, especially those used in the circulatory system, must exhibit excellent antithrombogenicity. The antithrombogenicity of newly developed biomaterials is generally evaluated by in vitro tests and animal experiments. For in vitro tests, several methods such as the modi ed Lee-White method and analysis using computational uid dynamics (CFD) have been reported [1, 2] . However, no standard in vitro method for the evaluation of antithrombogenicity has been established.
Thrombi are formed based on Virchow s triad (blood components, abnormalities in the bloodstream, and properties of the surface that comes in contact with blood) [3] . During in vivo thrombus formation, these three factors interact mutually, complicating the mechanisms of thrombus development and making it dif cult to evaluate antithrombogenicity adequately using only in vitro tests. In animal experiments, it is dif cult to measure the chronological changes of thrombi caused by contact of the biomaterials with blood in real time. Therefore, to evaluate antithrombogenicity, in vitro tests and animal experiments have to be repeated, requiring the use of many experimental animals. In 1959, the principle of 3Rs (replacement, reduction, and re nement) in animal experiments was proposed by Russell and Burch [4] . The development of useful in vitro evaluation methods that would reduce the numbers of experimental animals is our social responsibility. The development of an in vitro method to evaluate antithrombogenicity is an important task contributing to the development of biomaterials.
Synthetic polymer materials and tissue-derived biomaterials are used in many biomaterials requiring antithrombogenicity [5] [6] [7] [8] [9] . Platelets adhere to the adsorbed proteins on the surface of polymers that come in contact with the blood [10, 11] . Thus, in tissue-derived biomaterials, the exposed collagen may induce platelet aggregation. Adhesion and aggregation of platelets may be involved in the progression of the coagulation cascade [12, 13] . Hence, platelets are important in thrombus formation. Quantifying platelet aggregation on the surface of a biomaterial should provide an index of the antithrombogenicity of the material. Platelets, when aggregated, release functional molecules from secretory granules into the blood, which function to accelerate the blood coagulation reaction. Dense granules, a type of secretory granules, contain ADP, ATP, serotonin, histamine, and calcium ions, among other components, and release these functional molecules into the blood during secondary aggregation of plate-lets [14] . Luciferin-luciferase (L-L), the luminescent material of the re y, emits light with peak wavelength near 560 nm in the presence of ATP. Plotting the concentration of ATP and the emission intensity on a double logarithmic graph provides a linear relationship between these two parameters. In other words, the ATP concentration of a solution can be estimated from the emission intensity. In 1977, Feinman et al. [15] reported a method that applies this L-L reaction to measure the concentration of ATP released from platelets. In recent years, this principle has been used for veri cation of the effects of antiplatelet drugs, evaluation of antimicrobial fabrics, and other applications [16, 17] When secondary aggregation of platelets occurs in blood in the presence of the L-L luminescent reagent, the reagent reacts with ATP released from dense granules and emits light. The emission intensity is known to change chronologically according to the absolute amount of platelet aggregation. The change in emission intensity is predicted to re ect the nal amount of thrombus formation [18] . Thus, in this study, we constructed an experimental apparatus that uses a photomultiplier tube (PMT) to detect light emission sensitively from the L-L luminescent reagent accompanying platelet aggregation. Moreover, through in vitro aggregation of whole human blood or plasma with a controlled platelet concentration, we examined the relationship between blood coagulation and the emission intensity. Furthermore, by analyzing the relationship between thrombus formation and emission intensity in an in vitro blood circulation circuit, the usefulness of this evaluation system was veri ed. Last, antithrombotic evaluation of a porcine carotid artery as an arti cial vessel model was conducted, and the applicability of this experimental system was veri ed.
Materials and methods

Experimental apparatus
A PMT, which is a highly sensitive, low-noise, and rapid detection instrument (H7360-01; Hamamatsu Photonics K.K., Shizuoka, Japan: spectral response from 300 to 650 nm), was used as the photodetector, and the emission intensity was measured by the photon counting method. The output pulse of the PMT was counted using a photon counter connected to a one-chip microcomputer (peripheral interface controller: PIC). In a performance test using a function generator, this photon counter detected pulse signals between 10 Hz and 1 MHz with a maximum error of 0.07%. One pulse corresponded to the input for one photon, and the sum of the number of photons input to the PMT in 1 s was output as the emission intensity. Therefore, the PMT was expected to be accurate within the range from 10 1 to 10 6 counts/s. An overview of the experimental apparatus is shown in Fig. 1 . A PMT was installed in a light-shielding box, and a glass test tube (φ12 × 75 mm; Fig. 1a) or a blood circulation circuit (Fig. 1b) was set 35 mm from the photoelectric surface. The blood circulation circuit, composed of a polyvinyl chloride (PVC) tube (Senko Medical Instrument Manufacturing Co., Ltd., Tokyo, Japan) with an internal diameter of 3.3 mm and an external diameter of 5.0 mm, had a circuit length of 115 mm, and the volume of the lling liquid was 13 mL. Two types of PVC tubes were used: one without anticoagulation treatment (N-PVC) and the other with heparin coating (HC-PVC). Blood ow was controlled by a roller pump (model 10-20-00; Stockert Instr., Freiburg, Germany). To block incoming light that causes noise, a light-shielding board with a hole 10 mm in diameter was placed between the photoelectric surface and the sample. As shown in Fig. 1b , biomaterials such as arti cial vessels could be connected as a part of the circuit (M section). Drying of the material was prevented by lling the M section with saline. The experiments were all conducted at room temperature (25 C).
Luminescent reagent
Lucifer-250 and Lucifer-HS (high-sensitivity type) from Kikkoman Biochemifa Co. (Tokyo, Japan) were used as L-L luminescent reagents. Lucifer-250 was used to detect emission from the glass tube (Fig. 1a) . Lucifer-HS that emits light stronger than Lucifer-250 was used in the circulation circuit (Fig. 1b) , because emission from a part of the circulating blood (blood owing in front of the 10-mm hole) was detected.
Fresh blood sampling and anticoagulation
In this study, we used human blood sampled from a speci c researcher immediately before the experiment. Sampling and handling of blood were conducted with the approval of the Aino University Research Ethics Committee (approval numbers Aino2012-003 and Aino2014-004). The sampled blood was anticoagulated by adding 4 units (4 μL) of heparin per mL of blood.
Analysis of ATP detection sensitivity
We examined the sensitivity of ATP detection of the experimental apparatus. Two hundred microliters of an ATP standard solution adjusted to a concentration between 2 × 10 −11 and 2 × 10 −6 M was added to a test tube (Fig. 1a) . Then, 100 μL of Lucifer-250 or Lucifer-HS was added, and the emission intensity was measured with the PMT.
Detection of emission accompanying coagulation of blood in a test tube
Next, 200 μL of whole blood or plasma with a controlled platelet concentration was added to a test tube (Fig. 1a) . Four microliters of protamine sulfate and 100 μL of Lucifer-250 were added to induce blood coagulation, and the emission intensity was measured. To verify that the emission detected in this experiment was a phenomenon accompanying platelet aggregation, Lucifer-250 (without protamine) was added alone to the test tube containing whole blood or plasma, and the emission intensity was measured. The platelet concentration was adjusted in the following manner. Whole blood was centrifuged at 1000 rpm (190 × g) for 5 min, and the supernatant was collected as platelet-rich plasma (PRP). After collecting the PRP, the blood was further centrifuged at 3000 rpm (1750 × g) for 10 min, and the supernatant was collected as platelet-poor plasma (PPP). The numbers of platelets in PRP and PPP were calculated. The PRP and PPP were mixed to obtain plasma samples with different concentrations of platelets. The concentrations of erythrocytes and platelets in the blood used in the experiment were calculated using the Burker-Turk counting chamber.
Detection of emission accompanying coagulation of circulating blood
Whole blood was added to the circulation circuit (Fig. 1b) and was circulated at a constant ow. Fifty microliters of protamine sulfate and 50 μL of Lucifer-HS were then added to induce blood coagulation, and the emission intensity was measured. The blood ow was set at 20, 30, 50, or 90 mL/min. After the experiment, the thrombus formed within the circuit was washed with saline and collected on lter paper. The thrombus was dried overnight at 40 C, and the dry weight was measured. The circulation circuit was made of N-PVC.
Evaluation of antithrombogenicity of biomaterials
To examine the feasibility of using this experimental system to evaluate antithrombogenicity of biomaterials, circulation tests were conducted using arti cial vessel models of porcine carotid artery and porcine carotid artery crosslinked with glutaraldehyde (GA), the latter of which is commonly used as a material for articial vessels [8, 9] . A porcine carotid artery removed from a slaughtered and dissected pig was purchased from Tokyo Shibaura Zouki Co., Ltd. (Tokyo, Japan), washed with saline, and cryopreserved at −80 C. Before use, the carotid artery was thawed in saline at room temperature. Crosslinking by GA was performed by immersing the carotid artery in 0.2% GA at 4 C for 24 h. The porcine carotid artery was connected to the M section (Fig. 1b) of the circulation circuit with a length of 20 mm (including the portion for connection, a vessel with a total length of 50 mm was used). To prevent thrombus formation in the circuit other than in the M section, the circulation circuit was made of HC-PVC. For comparison, the emission intensity of a circulation circuit entirely composed of HC-PVC was measured. The emission accompanying platelet aggregation was transmitted through the carotid artery and input to the PMT. The light transmittance at the emission wavelength of Lucifer-HS for the porcine carotid was obtained in advance, and the measured emission intensity was corrected according to this value. Transmittance was calculated by reacting Lucifer-HS with a standard ATP reagent at a known concentration, and the transmitted light was measured with the PMT.
Histology
Hematoxylin and eosin (H&E) staining was conducted to observe the lumen of the porcine carotid artery. The sample was xed in 10% neutrally buffered formalin for 24 h at room temperature. After washing with phosphate-buffered saline (PBS), the sample was dehydrated with ethanol, replaced with xylene, and then embedded in paraf n. The embedded sample was cut into thin sections in the direction of the long axis to a thickness of 4 μm and was H&E stained. The stained section was observed under an optical microscope.
Statistical analysis
Correlation analysis was performed using Pearson s correlation test (p = signi cance, r = correlation coef cient). Data were considered signi cant when P < 0.05. Figure 2a shows typical chronological changes in emission intensity after the addition of Lucifer-250 or Lucifer-HS to the standard ATP reagent. The emission intensity increased upon addition of the luminescent reagent, reached the maximum emission intensity (E M ), and then declined. The E M for Lucifer-HS was approximately 20 times greater than the value for Lucifer-250, and the emission intensity decreased earlier for Lucifer-HS than for Lucifer-250. The E M for Lucifer-250 and Lucifer-HS were plotted against ATP concentrations on a double logarithmic graph, and a linear relation was obtained (Fig. 2b) . Figure 3a shows the chronological changes in emission intensity upon addition of reagents (Lucifer-250 and protamine) to a test tube containing whole blood or plasma. The reagents were added at time 0. The erythrocyte count of the whole blood was 492 × 10 4 cells/μL, and the platelet count was 23 × 10 4 cells/μL. No erythrocytes were found in the plasma, and the platelet concentration in the plasma was 28 × 10 4 cells/μL. The emission intensities from whole blood and plasma increased upon addition of the luminescent reagents, reached the E M , and then declined. The E M was reached earlier for whole blood than for plasma. On the other hand, the emission intensity increased slightly when only Luifer-250 was added (without protamine). Furthermore, a red thrombus (Fig. 3b) for whole blood and a white thrombus (Fig. 3c) for plasma were formed only in test tubes containing protamine. Figure 4 shows the relationship between platelet concentration in plasma and E M . A strong correlation between the two (r = 0.887, p = 0.00001, n = 15) was observed. Figure 5a shows chronological changes in emission intensity for blood ow at 20, 30, 50, and 90 mL/min in a test using blood sampled at the same time. The emission intensity increased immediately after addition of reagents (Lucifer-HS and protamine) and then decreased gradually. Then, the emission intensity began to increase again and reached E M . A characteristic sharp increase in emission intensity near the E M was detected as blood ow decreased. Since the emission intensity increased and decreased dramatically near E M , the values of E M were calculated from the moving average. Furthermore, the increase in emission intensity immediately after addition of reagents was assumed to be caused by the reaction between free ATP in the blood and Lucifer-HS. Thus, the time at which emission intensity increased again was labeled as T L (lag time), and E M was measured as the difference in emission intensity between that at T L and the peak (Fig. 5b) . In this study, lag time was considered to be the time from addition of protamine to the start of platelet aggregation. After the test, the circuit was washed with saline, and visible thrombus clots were found in experiments under all conditions (Fig. 5c) . The dry weight of this thrombus and the E M correlated signi cantly and negatively with blood ow (Fig. 6a, b) . Additionally, the dry weight of thrombus and the E M showed a signi cant, strong positive correlation (Fig. 6c) .
Results
ATP detection sensitivity
Chronological changes in platelet aggregation and emission intensity
Thrombus formation and emission intensity of circulating blood
Evaluation of antithrombogenicity of biomaterials
The porcine carotid artery connected to the circulation circuit is shown in Fig. 7a . H&E staining of the untreated artery showed that the endothelial cells were partially peeled off and collagen bers were exposed (Fig. 7b) . Measurement of the emission intensity in the circulation test showed no increase in emission intensity from the circuit entirely made of HC-PVC (Fig. 7c) . However, the emission intensity increased in the circuit connected to a carotid artery (Fig. 7d) . On the other hand, no increase in emission intensity was observed in the circuit connected to a GA-crosslinked carotid artery (Fig. 7e) . After the test, the circuit was washed with saline, and visible thrombus clots (Fig. 7d) were found only in the circuit connected to an untreated carotid artery. Figure 7d and e shows the corrected transmittance from a native and a GA-crosslinked porcine carotid artery, respectively.
Discussion
In this study, we aimed to develop a method to evaluate the antithrombogenicity of biomaterials by optical detection of platelet aggregation occurring on the surface of biomaterials. The apparatus we developed used the L-L reaction to detect thrombus formation indirectly via ATP. This experimental apparatus was able to detect emission intensity corresponding to the amount of platelet aggregation. Thus, this experimental system may be a useful alternative to animal experiments for the evaluation of antithrombogenicity of biomaterials.
Our experimental apparatus was capable of detecting ATP Fig. 4 Relationship between platelet concentration in plasma and maximum emission intensity (E M ). (154)
concentration in a solution with high sensitivity by measuring the E M for two luminescent reagents. The emission intensity increased as the luminescent reagent consumed ATP. Lucifer-HS was adjusted to emit light at an intensity approximately 20 times stronger than Lucifer-250, and the initial rapid attenuation of the emission intensity of Lucifer-HS was presumed to be caused by early consumption of ATP. Interestingly, we observed an obvious increase in emission intensity and thrombus formation upon addition of protamine, suggesting that the change in emission intensity was caused by neutralization of heparin following addition of protamine and was thus based on the coagulation activity of blood. Moreover, we found that the E M increased in proportion to the amount of platelet aggregation, suggesting that quanti cation of platelet aggregation on the surface of biomaterials is possible with this experimental system. Moreover, this system allowed chronological detection of platelet aggregation by measuring changes in emission intensity. The red thrombus shown in Fig. 3b is mainly composed of brin and erythrocytes. Thrombin, which is produced during the formation of brin, functions as a promoter of platelet aggregation [12] . The sharp increase in emission intensity when the red thrombus was formed was assumed to be caused by the accelerated release of ATP attributed to the platelet aggregation function of thrombin. Kawakami et al. [19] have shown that erythrocytes in static blood activate factor IX during blood coagulation on the surface of the membrane to shorten the coagulation time compared to that of plasma without erythrocytes. In this study, we detected strong emission intensity at an early stage for whole blood with erythrocytes, and this result was consistent with previous reports. However, a brin-forming pathway that does not directly involve platelet aggregation is also present in the coagulation cascade. Therefore, further studies are required to determine the relationship between the increase in emission intensity accompanying coagulation of whole blood and thrombus formation. In contrast, the white thrombus in Fig. 3c was mainly composed of platelets. Blood circulation with low ow causes stagnation, and momentary stagnation of blood facilitates thrombus formation. In our veri cation study using in vitro blood circulation circuit, a characteristic increase in emission intensity was observed at low ow (Fig. 5a) . This phenomenon may be caused by detection of stagnation at low ow, but further analyses are required. Thrombi are formed through the involvement of various factors in the coagulation system. Therefore, the increase in ATP concentration accompanying platelet aggregation does not necessarily re ect the nal step of thrombus formation. However, there was a significant strong correlation between the dry weight of thrombus formed in the circulation circuit and the E M . This result suggests that our novel experimental system is useful for the evaluation of antithrombogenicity of biomaterials.
In our evaluation of the antithrombogenicity of biomaterials, HC-PVC was highly antithrombotic compared to N-PVC. In experiments using the porcine carotid artery, the increase in emission intensity was suppressed by crosslinking with GA. In the untreated porcine carotid artery, collagen, a factor for platelet aggregation, was partially exposed, and consequently promoted thrombus formation. In this experimental system, since the change in ATP concentration of blood accompanying platelet aggregation was detected in real time, the emission intensity obtained was assumed to include the thrombus detached from the surface of the biomaterials by blood ow. Thus, this method has major advantages as an alternative method to animal experiments.
Finally, the design of the experimental apparatus, as shown in Fig. 1 , has not been optimized. By designing an optimal apparatus for the detection of the emission intensity, the measurement accuracy is expected to improve further.
Further studies of this experimental system are required to determine the relationship between platelet aggregation and thrombus formation on the surface of biomaterials and to interpret the chronological changes in emission intensity, including changes related to lag time, emission duration, and gradient of change in emission intensity. However, we have shown that this method is useful as an alternative to animal experiments and may be adapted for evaluation of antithrombogenicity of biomaterials. was exposed on the endothelium of the porcine carotid artery; (c) emission intensity did not increase when a heparin-coated tube was used in the entire circuit; (d) emission intensity increased by connecting the circuit to a porcine carotid artery; (e) emission intensity did not increase when the porcine carotid artery was crosslinked by glutaraldehyde.
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Conclusion
In this study, we aimed to develop an in vitro method for evaluating the antithrombogenicity of biomaterials by optically detecting platelet aggregation as a luminescence phenomenon utilizing the L-L reaction. In a test tube containing plasma, a signi cant, strong positive correlation was observed between the platelet concentration in plasma and the emission intensity. In a circulation circuit model containing whole blood, a signi cant, strong positive correlation was found between the dry weight of the formed thrombus and the maximum emission intensity (E M ). These results suggest that the changes in ATP concentration in blood accompanying platelet aggregation re ect the extent of thrombus formation. In a circulation test using a porcine carotid artery, thrombogenicity of the material surface was detected as change in emission intensity. This experimental system was proven to be useful as an alternative to animal experiments and is expected to be adapted for the evaluation of antithrombogenicity of biomaterials.
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